Assess efficacy of vardenafil within 6 hours after...
Date First Received: April 24, 2008
Last Updated: April 27, 2008
Verified by: Bayer, April 2008
Clinical Trial Phase: Phase 3 | Start Date: January 2003
Overall Status: Completed
Estimated Enrollment: 1200
Brief Summary
Official Title: “An Open-Label, Multicenter Study to Assess Safety, Tolerability, Efficacy and Impact on Quality of Life of Vardenafil 10mg in Patients With Erectile Dysfunction Within a Time Window of up to 6 Hours After Intake of Study Drug”
Condition Keyword(s):
Intervention(s):
Assess efficacy of vardenafil within 6 hours after intake
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Intervention(s) in this Clinical Trial
- Drug: Levitra (Vardenafil, BAY38-9456)
- Vardenafil 10mg orally on demand prior to intercourse
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: Arm 1
Outcome Measures for this Clinical Trial
Primary Measures
- Successful attempt rate reported between drug ingestion and a maximum of 6 hours after drug intake
- Time Frame: 12 weeks
Safety Issue?: No
- Time Frame: 12 weeks
Secondary Measures
- International Index of Erectile Function
- Time Frame: 12 weeks
Safety Issue?: No
- Time Frame: 12 weeks
- Global Assessment Question (GAQ)
- Time Frame: 12 weeks
Safety Issue?: No
- Time Frame: 12 weeks
- Other diary responses
- Time Frame: 12 weeks
Safety Issue?: No
- Time Frame: 12 weeks
- General Safety
- Time Frame: 12 weeks
Safety Issue?: Yes
- Time Frame: 12 weeks
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Age: 18 years and older
- Males with erectile dysfunction
- Stable heterosexual relationship
Exclusion Criteria:
- Primary hypoactive sexual desire
- History of myocardial infarction, stroke or life-threatening arrhythmia within the prior 6 months
- Nitrate use
Gender Eligibility for this Clinical Trial: Male
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Bayer
Overall Clinical Trial Officials and Contacts
Bayer Study Director Study Director Bayer
Additional Information
Information obtained from ClinicalTrials.gov on August 29, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00668018
Study ID Number: 10678
ClinicalTrials.gov Identifier: NCT00668018
Health Authority: Germany: Federal Institute for Drugs and Medical Devices
Click here to find results for studies related to marketed products
Click here and search for drug information provided by the FDA
Click here and search for information on any recalls, market or product safety alerts by the FDA
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.